Anti‐Tumor Immunity Induced by a Ternary Membrane System Derived From Cancer Cells, Dendritic Cells, and Bacteria
Small · 2023-12 · 19 (50)
DOI: 10.1002/smll.202302756 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 21.08.2023. Verfasst von He Ren und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering and Technology, Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin, 300350,…. Hauptthemen laut MEDLINE: Neoplasms, Cancer Vaccines. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program, National Key Research and Development Program of China.
Abstract (Originalsprache)
Cancer vaccines generally are limited by insufficient tumor‐specific cellular immunogenicity. Herein, a potent “ABC” ternary membrane‐derived vaccine system blended from antigen‐presenting mature dendritic cell membranes (“A”), bacterial E. coli cytoplasmic membranes (“B”), and cancer cell membranes (“C”) is developed using a block‐copolymer micelle‐enabled approach. The respective ABC membrane components provide for a source of cellular immune communication/activation and enhanced accumulation in lymph nodes (A), immunological adjuvant (B), and tumor antigens (C). The introduction of dendritic cell (DC) membranes enables multiple cell‐to‐cell communication and powerful immune activation. ABC activates dendritic cells and promotes T‐cell activation and proliferation in vitro. In vivo, ABC is 14‐ and 304‐fold more immunogenic than binary (BC) and single (C) membrane vaccines, and immunization with ABC enhances the frequency of tumor‐specific cytotoxic T lymphocytes, leading to an 80% cure rate in tumor‐bearing mice. In a surgical resection and recurrence model, ABC prevents recurrence with vaccination from autologous cancer membranes, and therapeutic effects are observed in a lung metastasis model even with heterologous cancer cell membranes. ABCs formed from human cancer patient‐derived tumor cells activate human monocyte‐derived dendritic cells (moDC). Taken together, the ternary ABC membrane system provides the needed functional components for personalized cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering and Technology, Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin, 300350, P. R. China.
- School of Life Science and Technology, Weifang Medical University, Shandong, 261000, P. R. China.
- The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Key Laboratory of Cancer Prevention and The…
- Department of Biomedical Engineering, State University of New York at Buffalo, Buffalo, NY, 14260, USA.
ORCID-Profile: Yumiao Zhang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program
- National Key Research and Development Program of China
Zitieren
APA
Ren, H., Li, J., Zhang, J., Liu, J., Yang, X., Zhang, N., Qiu, Q., Li, D., Yu, Y., Liu, X., Lovell, J. F., & Zhang, Y. (2023). Anti‐Tumor Immunity Induced by a Ternary Membrane System Derived From Cancer Cells, Dendritic Cells, and Bacteria. Small, 19(50). https://doi.org/10.1002/smll.202302756
Vancouver
Ren H, Li J, Zhang J, Liu J, Yang X, Zhang N, et al. Anti‐Tumor Immunity Induced by a Ternary Membrane System Derived From Cancer Cells, Dendritic Cells, and Bacteria. Small. 2023;19(50). doi:10.1002/smll.202302756
BibTeX
@article{Ren2023,
author = {Ren, He and Li, Jiexin and Zhang, Jingyu and Liu, Jingang and Yang, Xingyue and Zhang, Nan and Qiu, Qian and Li, Dan and Yu, Yue and Liu, Xiaofeng and Lovell, Jonathan F and Zhang, Yumiao},
title = {Anti‐Tumor Immunity Induced by a Ternary Membrane System Derived From Cancer Cells, Dendritic Cells, and Bacteria},
journal = {Small},
year = {2023},
volume = {19},
number = {50},
doi = {10.1002/smll.202302756}
}
EUVIMED